Satoshi Iwayama

543 total citations
14 papers, 448 citations indexed

About

Satoshi Iwayama is a scholar working on Epidemiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Satoshi Iwayama has authored 14 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Satoshi Iwayama's work include Cytomegalovirus and herpesvirus research (5 papers), Herpesvirus Infections and Treatments (4 papers) and HIV/AIDS drug development and treatment (3 papers). Satoshi Iwayama is often cited by papers focused on Cytomegalovirus and herpesvirus research (5 papers), Herpesvirus Infections and Treatments (4 papers) and HIV/AIDS drug development and treatment (3 papers). Satoshi Iwayama collaborates with scholars based in Japan, United States and United Kingdom. Satoshi Iwayama's co-authors include Katsuya Suzuki, Nobukazu Ono, Miki Fujimura, Danye Cheng, Yuiko Morita‐Fujimura, Midori A. Yenari, Gary K. Steinberg, Guo Hua Sun, Pak H. Chan and Ryo Kobayashi and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Satoshi Iwayama

14 papers receiving 435 citations

Peers

Satoshi Iwayama
Hiroshi Homma Japan
Kathryn Welch United States
Yumi Ogawa Japan
Judy Ly United States
Emmanuel K. Dayao United States
S. C. Flores United States
Ruth N. Harada United States
James M. Schmidt United States
Miguel Martı́-Cabrera Spain
Toru Mochizuki Japan
Hiroshi Homma Japan
Satoshi Iwayama
Citations per year, relative to Satoshi Iwayama Satoshi Iwayama (= 1×) peers Hiroshi Homma

Countries citing papers authored by Satoshi Iwayama

Since Specialization
Citations

This map shows the geographic impact of Satoshi Iwayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Iwayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Iwayama more than expected).

Fields of papers citing papers by Satoshi Iwayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Iwayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Iwayama. The network helps show where Satoshi Iwayama may publish in the future.

Co-authorship network of co-authors of Satoshi Iwayama

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Iwayama. A scholar is included among the top collaborators of Satoshi Iwayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Iwayama. Satoshi Iwayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nakamura, Toshitaka, Makoto Itoh, Hiromichi Yamaguchi, et al.. (2012). The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study. Journal of Bone and Mineral Metabolism. 30(6). 715–721. 7 indexed citations
2.
Yamamoto, Takashi, Seiji Niwa, Tomoyuki Onishi, et al.. (2012). Discovery and evaluation of selective N-type calcium channel blockers: 6-Unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 22(11). 3639–3642. 11 indexed citations
3.
Yamamoto, Takashi, Seiji Niwa, Masako Hagihara, et al.. (2011). Asymmetric synthesis and biological evaluations of (+)- and (−)-6-dimethoxymethyl-1,4-dihydropyridine-3-carboxylic acid derivatives blocking N-type calcium channels. Bioorganic & Medicinal Chemistry Letters. 21(11). 3317–3319. 13 indexed citations
4.
Yamamoto, Takashi, Koichi Fujita, Sayaka Asari, et al.. (2007). Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists. Bioorganic & Medicinal Chemistry Letters. 17(13). 3736–3740. 26 indexed citations
5.
Yamamoto, Takashi, Seiji Niwa, Satoshi Iwayama, et al.. (2006). Discovery, structure–activity relationship study, and oral analgesic efficacy of cyproheptadine derivatives possessing N-type calcium channel inhibitory activity. Bioorganic & Medicinal Chemistry. 14(15). 5333–5339. 21 indexed citations
6.
Takahara, Akira, et al.. (2003). Neuronal Ca2+ Channel Blocking Action of an Antihypertensive Drug, Cilnidipine, in IMR-32 Human Neuroblastoma Cells. Hypertension Research. 26(9). 743–747. 29 indexed citations
7.
Yenari, Midori A., Satoshi Iwayama, Danye Cheng, et al.. (2002). Mild Hypothermia Attenuates Cytochrome C Release but Does Not Alter Bcl-2 Expression or Caspase Activation after Experimental Stroke. Journal of Cerebral Blood Flow & Metabolism. 22(1). 29–38. 95 indexed citations
8.
Iwayama, Satoshi, Katsuya Suzuki, Nobukazu Ono, et al.. (1999). Evaluation of anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl]guanine (A-5021) in mice. Antiviral Research. 42(2). 139–148. 12 indexed citations
9.
Onishi, Tomoyuki, Ryusuke Nakagawa, Miho Aoki, et al.. (1999). Synthesis and Antiviral Activity of Novel Anti-VZV 5-Substituted Uracil Nucleosides with a Cyclopropane Sugar Moiety. Journal of Medicinal Chemistry. 43(2). 278–282. 29 indexed citations
10.
Ono, Nobukazu, Satoshi Iwayama, Katsuya Suzuki, et al.. (1998). Mode of Action of (1′ S ,2′ R )-9-{[1′,2′-Bis(hydroxymethyl) cycloprop-1′-yl]methyl}guanine (A-5021) against Herpes Simplex Virus Type 1 and Type 2 and Varicella-Zoster Virus. Antimicrobial Agents and Chemotherapy. 42(8). 2095–2102. 25 indexed citations
11.
Ono, Nobukazu, et al.. (1998). Synthesis and Antiviral Activity of Novel Acyclic Nucleosides:  Discovery of a Cyclopropyl Nucleoside with Potent Inhibitory Activity against Herpesviruses. Journal of Medicinal Chemistry. 41(8). 1284–1298. 105 indexed citations
12.
Iwayama, Satoshi, Nobukazu Ono, Katsuya Suzuki, et al.. (1998). Antiherpesvirus Activities of (1′ S ,2′ R )-9-{[1′,2′-Bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine (A-5021) in Cell Culture. Antimicrobial Agents and Chemotherapy. 42(7). 1666–1670. 26 indexed citations
13.
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Homma Breakdown of academic impact, for papers by Kathryn Welch Breakdown of academic impact, for papers by Yumi Ogawa Breakdown of academic impact, for papers by Judy Ly Breakdown of academic impact, for papers by Emmanuel K. Dayao Breakdown of academic impact, for papers by S. C. Flores Breakdown of academic impact, for papers by Ruth N. Harada Breakdown of academic impact, for papers by James M. Schmidt Breakdown of academic impact, for papers by Miguel Martı́-Cabrera Breakdown of academic impact, for papers by Toru Mochizuki
Rankless by CCL
2026